ICF International provides consulting, technology and data services, largely to US federal agencies in health, climate, disaster resilience and defence-adjacent programmes, plus commercial clients in energy and transport. Its moat is in incumbency: long-running contracts with federal civilian agencies and a deep bench of cleared analysts, which makes re-competes sticky even when the top line is flat. Revenue growth is currently slightly negative at -0.3%, so the case rests on margin and cash conversion rather than expansion, with the 8.4% operating margin and 37.2% gross margin the figures to test against peers. At a trailing P/E of 18.1 and a forward P/E of 10.9, the market is pricing in a meaningful earnings recovery, and the gap between those two multiples is the first thing to pressure-test. The name is not in any index, which may be keeping coverage thin and the multiple below where its contract base alone would suggest, but a 8.6% ROE says the capital is not yet working hard enough to justify a closer look without evidence of margin repair.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 21 Oct 2026, 12:04 CEST | Rating | Undervalued | first publication | $89.78 |
| 21 Oct 2026, 12:04 CEST | Fair value | $106 | $124 | $89.78 |
| 16 Oct 2026, 00:00 CEST | Fair value | $124 | $135 | $86.67 |
| 12 Oct 2026, 00:00 CEST | ACCE price target | $96.00 | first publication | $87.55 |
| 12 Oct 2026, 00:00 CEST | Fair value | $135 | $129 | $87.55 |
| 28 Sept 2026, 00:00 CEST | Fair value | $129 | $131 | $83.56 |
| 25 Sept 2026, 00:00 CEST | Fair value | $131 | $129 | $83.68 |
| 18 Sept 2026, 00:00 CEST | Fair value | $129 | $132 | $87.46 |
| 10 Sept 2026, 00:00 CEST | Fair value | $132 | $134 | $87.25 |
| 5 Sept 2026, 00:00 CEST | Fair value | $134 | $140 | $90.00 |
Answered from ICF International Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| ICFI ICF International Inc. Common Stock | $94.40 | $106 | 11% below | 18.8x | 8.6% | 56 | 63 |
| IPS.PA Ipsos SA | €35.30 | €60 | 42% below | 8.8x | 11.9% | 67 | 62 |
| CRAI CRA International Inc. Common Stock | $200.14 | $140 | 43% above | 26.8x | 26.0% | 74 | 70 |
| HURN Huron Consulting Group Inc. Common Stock | $195.69 | $146 | 34% above | 28.0x | 26.9% | 69 | 77 |
| FCN FTI Consulting Inc. Common Stock | $157.24 | $166 | 5% below | 18.9x | 15.6% | 64 | 50 |
| SBC SBC Medical Group Holdings Incorporated Common Stock | $5.28 | $6 | 18% below | 11.2x | 18.9% | 95 | 89 |
| DKSH.SW DKSH Holding AG | CHF 77.10 | CHF 53 | 45% above | 23.7x | 12.6% | 40 | 62 |
Where ICFI ranks against its sector peers on each metric.